Lineage Cell Therapeutics, Inc.LCTXNYSE
Loading
Cash generated from core business operations
Percentile
P86
Within normal range
vs 3Y Ago
-17.9x
Contraction
Streak
2 yr
Consecutive growthExpanding
| Period | Value | YoY Change |
|---|---|---|
| 2025 | $-18.92M | +18.1% |
| 2024 | $-23.09M | +19.2% |
| 2023 | $-28.57M | -2797.5% |
| 2022 | $1.06M | +104.5% |
| 2021 | $-23.56M | -19.3% |
| 2020 | $-19.75M | +38.2% |
| 2019 | $-31.95M | -3.4% |
| 2018 | $-30.88M | -1.2% |
| 2017 | $-30.52M | +27.9% |
| 2016 | $-42.33M | - |